Company: SIMA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026255
Chunk: 62

Company: SIM Acquisition Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 62
---
 investments
over their careers. We believe this experience will allow our team to effectively position the target company with public market investors.
Additionally, the ability to effectively access the capital markets to either fund growth or right-size a company’s balance sheet
provides management teams with additional flexibility while running a business.

●Operational Value-Add:  Mr. Spangenberg
is a serial entrepreneur and has decades of experience operating businesses and driving value creation. This allows for a diverse set
of acquisition targets to be evaluated.

●Intellectual Property.  Mr. Spangenberg
has been involved as a principal in over 1,000 licensing transactions that generated over $360 million in revenue and as a principal and
advisor on over $2 billion of patent financing and acquisition transactions. Given healthcare companies, regardless of subsector, typically
have large (and growing) intellectual property portfolios, we believe the ability of our Management Team to help a target company optimize
and monetize its intellectual property portfolio provides a significant competitive advantage.

Acquisition Criteria

Consistent with our strategy,
we have identified the following general criteria and guidelines that we believe are important in evaluating prospective target businesses.
We use these criteria and guidelines in evaluating acquisition opportunities, but we may decide to enter into our initial Business Combination
with a target business that does not meet these criteria and guidelines. We intend to filter our opportunities based on the following
criteria:

●Industry Attractiveness:  Macro
industry dynamics including regulatory and reimbursement situation must be favorable on a go-forward basis;

●Value Proposition:  Driving savings
or growth for customers with a high return on investment;

●Business Model:  Margins and cost
structure supportive of additional investment;

●Growth Potential: Imbedded top-line
and bottom-line growth potential in near and long term;

●Competitive Position: Leading or
growing market share relative to peer group; and

●Management Team:  Talented, motivated
and aligned with equity investors.

2

These criteria are not intended
to be exhaustive. Any evaluation relating to the merits of a particular initial Business Combination may be based, to the extent relevant,
on these general guidelines as well as other considerations, factors and criteria that our Management Team may deem relevant. In the event
that we decide to enter into our initial Business Combination with a target business that does not meet the above criteria and guidelines,
we will disclose that the target business does not meet the above criteria in our shareholder communications related to our initial Business
Combination, which would